Technological Advancements in Interventional Cardiology and Peripheral Vascular Devices

Factors such as the aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are expected to drive the growth of this market.The interventional cardiology market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1%.

Get PDF Brochure Here: http://bit.ly/2uDGzna

Key players :

The major players in the interventional cardiology market include Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).

About Report :

On the basis of type, the angioplasty stent market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the angiography catheters segment is expected to account for the largest share of the market.On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is expected to account for the largest share primarily due to the rising incidence of smoking and hypertension.

Value Addition for the Buyer:

This report aims to provide insights into the global interventional cardiology & peripheral vascular devices market. It provides valuable information on interventional cardiology & peripheral vascular devices product segment and end user. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market.

To Know More About It: http://bit.ly/2uE8eog

Increasing Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications

The market is mainly driven by factors such as rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, increasing demand for synthetic genes, and increasing R&D expenditure in pharmaceutical and biotechnological companies.

Download PDF Brochure Here : http://bit.ly/2uBPHcp

The Oligonucleotide Synthesis Market  is expected to reach USD 2.20 Billion by 2021 from USD 1.33 Billion in 2016, at a CAGR of 10.6% from 2016 to 2021.

Key market players :

Agilent Technologies Inc. (U.S.), Bioautomation Corporation (U.S.), L.G.C Biosearch Technologies (U.S.), Eurofins Genomics (Germany), Eurogentec S.A (Belgium), GE Healthcare (U.S.), Integrated DNA Technologies (IDT) (U.S.), Nitto Denko Avecia Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Sigma-Aldrich Corporation (U.S.) (part of Merck KGaA (Germany)).

Market Geography :

The global market is dominated by North America, followed by Europe, Asia-Pacific, Latin America, Middle East and Africa. The market in Asia-Pacific is expected to grow at a highest CAGR during the forecast period. Factors such as the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the APAC region contribute to the growth of this oligonucleotide synthesis in Asia-Pacific region. Furthermore, the increasing focus of prominent players on APAC is another factor driving the growth of this market.

About Market :

On the basis of application the Oligonucleotide Synthesis Market  is further segmented into research, diagnostic and therapeutics. Research segment is expected to account for the largest share of Oligonucleotide Synthesis Market  in 2016. Diagnostic segment is expected to grow at the highest CAGR during the forecast period.

The growth of this segment is mainly attributed to the emerging application of molecular diagnostics (MDx) and genetic testing. The increasing use of technologies such as DNA microarrays in the analysis of biological samples and developing molecular oncology diagnostics tests also contribute in the growth of molecular diagnostics market.

To Know More : http://bit.ly/2vASxeT

Global Trends of Computerized Physician Order Entry Market

CPOE is an electronic entry process utilized by medical practitioners to enter medication orders and other treatment related instructions particularly for hospitalized patients under care. It reduces errors related to handwriting as well as reduces the time taken for order completion. The order entry is transmitted over a network to various departments within a hospital, including pharmacy, laboratory, and radiology.  

The global computerized physician order entry (CPOE) market was valued at $999.9 Million in 2014,and Computerized Physician Order Entry Market worth 379 Million USD by 2019, and is projected to grow at a CAGR of 6.6% during the forecast period from 2014 to 2019.

Get PDF  Brochure Here :http://bit.ly/2uxzd5g

Key players :

The key players profiled in the global CPOE market are Allscripts (U.S.), Athenahealth, Inc. (U.S.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Medical Information Technology, Inc. (U.S.), Cerner Corporation (U.S.), eClinicalWorks LLC (U.S.), Epic systems (U.S.), GE healthcare (U.K.), Mckesson Corporation (U.S.), and Carestream Health (U.S.). 

Market Geography :

The market, on the basis of region, has been classified into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. North America held the largest share of 59.5% in the total global CPOE market, which was followed by Europe. The rising number of installations in North America is due to the high adoption of advanced technology, wherein a greater emphasis is laid on hospital automation.

About Report :

The global CPOE Market has been segmented on the basis of five categories, namely, type, component, deployment, end-user, and region. On the basis of type, the market is segmented into integrated CPOE and standalone CPOE, wherein the integrated CPOE sub-segment dominated the global CPOE market with a share of 75.0% in 2014.

On the basis of component, this market is further divided into services, software, and hardware, wherein the services sub-segment has the largest market value. On the basis of deployment, this market is segmented into web-based, on premise, and cloud based, wherein the web-based sub-segment has the largest market value. 

To Know More : http://bit.ly/2uxwIQc 

The Current As Well As Future Prospects Of Endoscopy Medical Devices..!!

Major Factors Driving :

Increasing investments, funds, and grants by government bodies worldwide; rising number of hospitals and growing hospital investments in endoscopy instruments; growing patient preference for minimally invasive surgeries; technological advancements; favorable reimbursement coverage in select countries; and the rising prevalence of diseases Furthermore, growing healthcare market in the emerging economies and increasing number of free-trade agreements are to serve as opportunities in this market.

The endoscopy equipment market is projected to reach USD 35.36 Billion by 2021, growing at a CAGR of 6.2% during the forecast period of 2016 to 2021.

 

Download PDF Brochure Here : http://bit.ly/2xM4RtW

                                                                            

Endoscopes and endoscopy equipment is extensively used in laparoscopy, gastrointestinal endoscopy, arthroscopy, obstetrics/gynecological endoscopy, urology endoscopy, bronchoscopy, mediastinoscopy, otoscopy, and laryngoscopy, among others. On the basis of product, the market is segmented into endoscopes, visualization systems, other endoscopy equipment, and accessories.

Market Geography :                                           

The market is categorized into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is expected to grow at the highest rate during the forecast period. The major factors driving the growth of this market include German-Asian partnerships, endoscopy research support in Japan, government investments and venture capital investments in China, and the increasing number of endoscopic surgeries & improving endoscopy infrastructure in India.

 

Japan, being one of the leading nations in terms of technology and technological development, is the homeland for top players of the endoscopy market and a mature medical equipment manufacturing industry. Olympus Corporation, Fujifilm Holdings Corporation, Welch Allyn, and Pentax Medical (Hoya Corporation), among others, are some top players of the endoscopy equipment market headquartered in Japan. Their domestic presence offers an array of opportunities to garner a stronger market share in the country. This can be attributed to their greater awareness of the market as compared to foreign players, easy accessibility to the market, and easy availability of products to end users.

China, being an emerging nation for endoscopy equipment, has seen many investments by venture capitalists for small and medium-sized companies. In May 2015, DiNovA (China) Venture Capital invested in Shanghai Outai Medical Equipment Co., Ltd (China), which manufactures bronchoscopes, laryngoscopes, gastrointestinal video endoscopes, colonoscopes, and light sources. Furthermore, the company invested in three deals in China, as of May 2015. The company has the largest local distribution network in China, with approximately 120 distributors and strong distribution capabilities in Jiangsu, Shanghai, Zhejiang, and Shandong. The continuous influx of venture capital for local players in China is expected to aid the production of innovative and new devices in the region, thus propelling the market during the forecast period.

The Asia-Pacific Conference, which takes place in every two years, provides German and Asian decision-makers in the business and political arenas with a platform for exchanging ideas about the latest economic issues. These meetings help in building the relationship between Germany and Asian countries. Additionally, a majority of Asian countries have free trade agreements (FTAs) with Germany, making business in this region more favorable. The Chinese government considers free trade agreements as a new platform for speeding up growth and strengthening its economy. As of October 2015, China has 19 FTAs under consideration, of which 14 have been signed and implemented. Partnerships and FTAs stimulate the flow of innovative and high-quality medical technology and pharmaceuticals from Germany to the Asian healthcare market.

The rising middle class population, growing purchasing power, and adoption of westernized lifestyles, leading to the rising incidence of conditions such as obesity and cardiovascular disease, have created a significant demand for hospitals with improved infrastructure in India. This has triggered government initiatives to increase the bed capacities of existing hospitals and establish new hospitals. According to the Indian 12th Five Year Plan (2012-2017), the bed capacity of hospitals in the country is expected to be increased by 650,000 beds by 2017. Additionally, public and private investments have been made to establish new hospitals or expand/renovate existing facilities.

To Know More : http://bit.ly/2vDV9JB

Growing Demand for Aesthetic Orthodontic Treatments Among Teenagers and Adults | Drives Growth of Orthodontic Supplies Market

Factors driving the growth of the global Orthodontic Supplies market
The growing number of patients with malocclusion, jaw diseases, tooth decay/tooth loss, and jaw pain; increasing disposable income and expanding middle-class population in developing countries; increasing awareness among consumers about advanced orthodontic treatments; and technological advancements in orthodontic products are some key factors driving the growth of the global market.

The global Orthodontic Supplies Market  is expected to reach USD 4.71 Billion by 2021, at a CAGR of 8.0% during the forecast period.

Download PDF Brochure : http://bit.ly/2typ30Q

Key Players :
M Company (U.S.), Align Technology Inc. (U.S.), Danaher Corporation (U.S.), Henry Schein, Inc. (U.S.), DENTSPLY International, Inc. (U.S.), American Orthodontics (U.S.), Rocky Mountain Orthodontics, Inc. (U.S.), G&H Orthodontics, Inc. (U.S.), Dentaurum GmbH & Co. KG (Germany), and TP Orthodontics, Inc. (U.S.) are some key players operating in the global orthodontic supplies market.

On the basis of product, the global Orthodontic Supplies Market  is divided into three major categories, namely, fixed braces, removable braces, and orthodontic adhesives. Fixed Braces category is further divided into five orthodontic products segment, namely, brackets, by type (conventional, self-ligating, and lingual); brackets, by material (metal/traditional and ceramic/aesthetic); archwires (beta titanium, nickel titanium, and stainless steel); anchorage appliances (bands & buccal tubes and miniscrews); and ligatures (elastomeric ligatures and wire ligatures).

On the basis of region, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. This is primarily due to high prevalence of malocclusion and jaw disorders; growing efforts to increase awareness of advanced orthodontic treatments; growing focus of global orthodontic/dental companies on emerging APAC countries; and increasing disposable income coupled with growing middle class population in the APAC region.


                                           

TO Know More : http://bit.ly/2wDENRb

Gelatin-based Adhesives and Polyethylene Glycol Hydrogel Product Segment Are Expected to Show Significant Growth Opportunities during the Forecast Period 2014-21

The global surgical sealants and adhesives market is projected to reach USD 2.96 billion by 2021 from USD 1.87 billion in 2016, at a CAGR of 9.6% during the forecast period.

Major Factor Which Are Driving The Growth Of Surgical Sealants and Adhesives Market :

Increasing incidence of chronic diseases along with the rapid growth in the geriatric population, increasing need manage blood loss in patients, and growing number of surgical procedures performed are the major factors driving the growth of the surgical sealants and adhesives market

                                                           

Get PDF Brochure Here : http://bit.ly/2hMM8eA

On the basis of product, the market is segmented into natural/biological sealants and adhesives and synthetic & semi-synthetic sealants and adhesives. The natural/biological sealants and adhesives segment is further categorized into type and origin.

On the basis of type, the natural/biological sealants segment have been divided into polypeptide/protein-based and polysaccharide-based sealants and adhesives. The polypeptide/protein-based sealants segment is further categorized into fibrin, gelatin, collagen, and albumin-based adhesives, while the polysaccharide-based sealants segment comprise of chitosan-based and other polysaccharide-based adhesives.

 On the basis of origin, the natural/biological sealants and adhesives segment is categorized into human blood-based and animal-based. The synthetic and semi-synthetic sealants and adhesives segment is divided into cyanoacrylates, polyethylene glycol hydrogels, urethane-based adhesives, and other synthetic adhesives.

On the basis of application, the global surgical sealants and adhesives market is segmented into CNS, general, cardiovascular, orthopedic, cosmetic, urological, pulmonary, ophthalmic surgeries, and other applications.

To Know More : http://bit.ly/2fuaGZi

Global Surgical Lasers Device Growth Driven By Increasing Number of Target Diseases and Related Surgical Procedures

The global Surgical Lasers Market is projected to reach USD 2.37 Billion by 2021 from USD 1.85 Billion in 2016; growing at a CAGR of 5.1% during 2016-2021.

Key Factor Of Surgical Lasers Market  Growth :

•         Growing prevalence of chronic diseases,
•         Technological advancements,
•          Increasing incidence and prevalence of targeted diseases,
•          High prevalence of ophthalmic disorders. 

Download PDF Brochure Here : http://bit.ly/2uDL1Cw

In addition, growing preference for minimally invasive surgeries among patients and healthcare professionals is supporting the growth of the market.

Surgical Laser devices generate laser beams of specific wavelengths that is used during surgical procedures for tissue cutting, destruction, or clotting. These lasers find applications in the fields of ophthalmology, dermatology, gynecology, cardiology, and urology, among others. Moreover, carbon dioxide lasers, argon lasers, and diode lasers are the types of Surgical Lasers commonly used in the healthcare industry.

Market Geography :

North America and Europe are major contributors to the growth of the Surgical Lasers Market due to the rising prevalence of chronic diseases and the technological advancements in these regions. The Asia-Pacific region is expected to be the new revenue-generating market for players engaged in offering Surgical Laser products.

About Market :

Based on procedure type, the market is segmented into open surgery, laparoscopic surgery, and percutaneous surgery. The laparoscopic surgery segment is expected to dominate the market during the forecast period. This growth can be primarily attributed to the procedural benefits of laparoscopic procedures, growing patient awareness, and market demand for less-invasive disease therapies.

To Know More About It : http://bit.ly/2vcJ6Go